Skip to main content

A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive

Clinical Drug Investigation volume 40, pages 395–420 (2020)Cite this article

Abstract

Introduction

The levonorgestrel oral emergency contraceptive is well tolerated and effective, however its use is still limited, mainly due to safety concerns.

Objective

This systematic review and meta-analysis aimed to summarize current evidence regarding the adverse events, and their prevalence, reported during the use of oral levonorgestrel emergency contraceptives.

Methods

Four electronic databases and the US FDA Adverse Event Reporting System (FAERS) Public Dashboard were searched. Studies that reported or investigated safety outcomes or adverse reactions during the use of levonorgestrel as an emergency oral contraceptive were included. Data on study design, demographics of levonorgestrel and the control cohort, and reported adverse effects were extracted.

Results

A total of 47 articles were included in this systematic review, from which it was shown that most of the adverse reactions were common and not serious. Uncommon adverse reactions identified included anorexia, ectopic pregnancy, exanthema, chloasma, miscarriage, and weight gain. Multiple serious adverse events, including convulsion, ectopic pregnancy, febrile neutropenia, stroke, abdominal hernia, anaphylaxis, cancer, ovarian cyst rupture, serious infections, and suicidal ideation, were reported. In addition, the prevalence of adverse events after a levonorgestrel 0.75 mg two-dose regimen and a levonorgestrel 1.5 mg single-dose regimen were not statistically different (p > 0.05).

Conclusions

The most common adverse effects of levonorgestrel were not serious. This systematic review shows that data regarding the adverse reactions of repeated use of levonorgestrel are scarce. Studies on the multiple uses of levonorgestrel emergency contraception are still required to ensure its safety.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 49.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Black KI, Hussainy SY. Emergency contraception: oral and intrauterine options. Aust Fam Physician. 2017;46(10):722–6.

    PubMed  Google Scholar 

  2. Hansen LB, Saseen JJ, Teal SB. Levonorgestrel-only dosing strategies for emergency contraception. Pharmacotherapy. 2007;27(2):278–84.

    CAS  PubMed  Article  Google Scholar 

  3. Shohel M, Rahman MM, Zaman A, Uddin MM, Al-Amin MM, Reza HM. A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception. BMC Womens Health. 2014;14:54.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  4. Dinger JC, Cronin M, Mohner S, Schellschmidt I, Minh TD, Westhoff C. Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol. 2009;201(3):263.e1–9.

    Article  CAS  Google Scholar 

  5. Cleland K, Raymond EG, Westley E, Trussell J. Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol. 2014;57(4):741–50.

    PubMed  PubMed Central  Article  Google Scholar 

  6. Upadhya KK. Emergency contraception. Pediatrics. 2019;144(6):3149.

    Article  Google Scholar 

  7. Doci F, Thaci J, Foster AM. Emergency contraception in Albania: a multimethods qualitative study of awareness, knowledge, attitudes and practices. Contraception. 2018;98(2):110–4.

    Article  Google Scholar 

  8. Kongnyuy EJ, Ngassa P, Fomulu N, Wiysonge CS, Kouam L, Doh AS. A survey of knowledge, attitudes and practice of emergency contraception among university students in Cameroon. BMC Emerg Med. 2007;7:7.

    PubMed  PubMed Central  Article  Google Scholar 

  9. Kgosiemang B, Blitz J. Emergency contraceptive knowledge, attitudes and practices among female students at the University of Botswana: a descriptive survey. Afr J Primary Health Care Family Med. 2018;10(1):e1–6.

    Google Scholar 

  10. Said A, Ganso M, Freudewald L, Schulz M. Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists. Int J Clin Pharm. 2019;41(6):1499–506.

    PubMed  Article  Google Scholar 

  11. Free C, Lee RM, Ogden J. Young women’s accounts of factors influencing their use and non-use of emergency contraception: in-depth interview study. BMJ. 2002;325(7377):1393.

    PubMed  PubMed Central  Article  Google Scholar 

  12. Westley E, Glasier A. Emergency contraception: dispelling the myths and misperceptions. Bull WHO. 2010;88(4):243–4.

    PubMed  PubMed Central  Google Scholar 

  13. Zhang J, Li C, Zhao WH, Xi X, Cao SJ, Ping H, et al. Association between levonorgestrel emergency contraception and the risk of ectopic pregnancy: a multicenter case-control study. Sci Rep. 2015;5:8487.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. Assouni Mindjah YA, Essiben F, Foumane P, Dohbit JS, Mboudou ET. Risk factors for ectopic pregnancy in a population of Cameroonian women: a case-control study. PLoS One. 2018;13(12):e0207699.

    PubMed  PubMed Central  Article  Google Scholar 

  15. Kurian A, Kaushik K, Subeesh V, Maheswari E, Kunnavil R. Safety profile of levonorgestrel: a disproportionality analysis of food and drug administration adverse event reporting system (FAERS) database. J Reprod Infertil. 2018;19(3):152–6.

    PubMed  PubMed Central  Google Scholar 

  16. Jatlaoui TC, Riley H, Curtis KM. Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception. Contraception. 2016;93(2):93–112.

    CAS  PubMed  Article  Google Scholar 

  17. Cleland K, Raymond E, Trussell J, Cheng L, Zhu H. Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol. 2010;115(6):1263–6.

    PubMed  PubMed Central  Article  Google Scholar 

  18. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case–control study. BMJ. 2009;339:b2921.

    Article  Google Scholar 

  19. Farmer RDT, Lawrenson RA. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany. Am J Obstet Gynecol. 1998;179(3):s78–86.

    CAS  PubMed  Article  Google Scholar 

  20. Wilks JF. Hormonal birth control and pregnancy: a comparative analysis of thromboembolic risk. Ann Pharmacother. 2003;37(6):912–6.

    PubMed  Article  Google Scholar 

  21. Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: danish cohort study, 2001–9. BMJ. 2011;343:d6423.

    PubMed  PubMed Central  Article  Google Scholar 

  22. Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertil Steril. 2017;107(1):43-51.

  23. Najafi-Sharjabad F, Hajivandi A, Rayani M. Knowledge, attitude, and practice about emergency contraception among health staff in Bushehr state, south of Iran. Global J Health Sci. 2013;6(1):52–60.

    Article  Google Scholar 

  24. Byamugisha JK, Mirembe FM, Faxelid E, Gemzell-Danielsson K. Knowledge, attitudes and prescribing pattern of emergency contraceptives by health care workers in Kampala, Uganda. Acta Obstet Gynecol Scand. 2007;86(9):1111–6.

    PubMed  Article  Google Scholar 

  25. Harrison A. Knowledge and attitude towards emergency contraception among medical doctors in Delta State. Afr J Med Health Sci. 2014;13(1):39–46.

    Article  Google Scholar 

  26. Chung-Park M. Emergency contraception knowledge, attitudes, practices, and barriers among providers at a military treatment facility. Mil Med. 2008;173(3):305–12.

    PubMed  Article  Google Scholar 

  27. Sychareun V, Phongsavan K, Hansana V, Phengsavanh A. Policy maker and provider knowledge and attitudes regarding the provision of emergency contraceptive pills within Lao PDR. BMC Health Serv Res. 2010;10(1):212.

    PubMed  PubMed Central  Article  Google Scholar 

  28. Reactions Reporting Adverse Drug. Definitions of terms and criteria for their use. Geneva: World Health Organization; 1999.

    Google Scholar 

  29. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.

    PubMed  PubMed Central  Article  Google Scholar 

  30. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014 [cited 25 Nov 2019]. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

  31. Herzog R, Álvarez-Pasquin MJ, Díaz C, Del Barrio JL, Estrada JM, Gil Á. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review. BMC Public Health. 2013;13(1):154.

    PubMed  PubMed Central  Article  Google Scholar 

  32. Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2–10.

    PubMed  Article  Google Scholar 

  33. Pierson DJ. How to read a case report (or teaching case of the month). Respir Care. 2009;54(10):1372–8.

    PubMed  Google Scholar 

  34. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid-Based Med. 2018;23(2):60–3.

    PubMed  PubMed Central  Article  Google Scholar 

  36. Likis FE, Andrews JC, Collins MR, Lewis RM, Seroogy JJ, Starr SA, et al. AHRQ comparative effectiveness reviews. nitrous oxide for the management of labor pain. Rockville: Agency for Healthcare Research and Quality; 2012.

  37. Wallace BC, Schmid CH, Lau J, Trikalinos TA. Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol. 2009;9(1):80.

    PubMed  PubMed Central  Article  Google Scholar 

  38. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

    PubMed  PubMed Central  Article  Google Scholar 

  39. Bhattacharjee SK, Romeo J, Kononova ES, Pretnar-Darovec A, Saraya L, Shi YE, et al. Postcoital contraception with levonorgestrel during the peri-ovulatory phase of the menstrual cycle. Task force on post-ovulatory methods for fertility regulation. Contraception. 1987;36(3):275–86.

    CAS  PubMed  Article  Google Scholar 

  40. He CH, Shi YE, Xu JQ, Van Look PF. A multicenter clinical study on two types of levonorgestrel tablets administered for postcoital contraception. Int J Gynaecol Obstet. 1991;36(1):43–8.

    CAS  PubMed  Article  Google Scholar 

  41. Ho PC, Kwan MS. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod. 1993;8(3):389–92.

    CAS  PubMed  Article  Google Scholar 

  42. Lerkiatbundit S, Reanmongkol W. Use of 0.75 mg Levonorgestrel for postcoital contraception in Thailand. J Clin Pharm Ther. 2000;25(3):185–90.

    CAS  PubMed  Article  Google Scholar 

  43. Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Post-Ovulatory Methods of Fertility Regulation. Contraception. 2000;61(5):303-8.

  44. von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bartfai G, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet. 2002;360(9348):1803–10.

    Article  Google Scholar 

  45. Hamoda H, Ashok PW, Stalder C, Flett GM, Kennedy E, Templeton A. A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception. Obstet Gynecol. 2004;104(6):1307–13.

    CAS  PubMed  Article  Google Scholar 

  46. Harper CC, Rocca CH, Darney PD, von Hertzen H, Raine TR. Tolerability of levonorgestrel emergency contraception in adolescents. Am J Obstet Gynecol. 2004;191(4):1158–63.

    CAS  PubMed  Article  Google Scholar 

  47. Ngai SW, Fan S, Li S, Cheng L, Ding J, Jing X, et al. A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception. Hum Reprod. 2005;20(1):307–11.

    CAS  PubMed  Article  Google Scholar 

  48. Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol. 2006;108(5):1089–97.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  49. Raymond EG, Goldberg A, Trussell J, Hays M, Roach E, Taylor D. Bleeding patterns after use of levonorgestrel emergency contraceptive pills. Contraception. 2006;73(4):376–81.

    CAS  PubMed  Article  Google Scholar 

  50. Tirelli A, Cagnacci A, Volpe A. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function. Contraception. 2008;77(5):328–32.

    CAS  PubMed  Article  Google Scholar 

  51. Farajkhoda T, Khoshbin A, Enjezab B, Bokaei M, Karimi Zarchi M. Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe. Niger J Clin Pract. 2009;12(4):450–2.

    CAS  PubMed  Google Scholar 

  52. Hoseini FS, Eslami M, Abbasi M, Noroozi Fashkhami F, Besharati S. A randomized, controlled trial of levonorgestrel vs. the yuzpe regimen as emergency contraception method among Iranian women. Iran J Public Health. 2013;42(10):1158–66.

    PubMed  PubMed Central  Google Scholar 

  53. Dada OA, Godfrey EM, Piaggio G, von Hertzen H. A randomized, double-blind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria. Contraception. 2010;82(4):373–8.

    CAS  PubMed  Article  Google Scholar 

  54. Lech MM, Ostrowska L, Swiatek E. Emergency contraception in a country with restricted access to contraceptives and termination of pregnancy, a prospective follow-up study. Acta Obstet Gynecol Scand. 2013;92(10):1183–7.

    PubMed  Google Scholar 

  55. Taylor DJ, Lendvay A, Halpern V, Bahamondes LG, Fine PM, Ginde SY, et al. A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel. Contraception. 2014;89(3):215–21.

    CAS  PubMed  Article  Google Scholar 

  56. Arowojolu AO, Okewole IA. Vaginal bleeding following the use of a single dose of 1.5 mg levonorgestrel (LNG) for emergency contraception. West Afr J Med. 2004;23(3):191–3.

    CAS  PubMed  Google Scholar 

  57. Byamugisha JK, Mirembe FM, Faxelid E, Tumwesigye NM, Gemzell-Danielsson K. A randomized clinical trial of two emergency contraceptive pill regimens in a Ugandan population. Acta Obstet Gynecol Scand. 2010;89(5):670–6.

    CAS  PubMed  Article  Google Scholar 

  58. Chen QJ, Xiang WP, Zhang DK, Wang RP, Luo YF, Kang JZ, et al. Efficacy and safety of a levonorgestrel enteric-coated tablet as an over-the-counter drug for emergency contraception: a Phase IV clinical trial. Hum Reprod. 2011;26(9):2316–21.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  59. Festin MP, Bahamondes L, Nguyen TM, Habib N, Thamkhantho M, Singh K, et al. A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg. Hum Reprod. 2016;31(3):530–40.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010;375(9714):555–62.

    CAS  PubMed  Article  Google Scholar 

  61. Mittal S, Sehgal R, Jindal VI, Sikka P, Kandpal S, Maiti L, et al. Single dose levonorgestrel and two regimens of centchroman for emergency contraception. J Turk Ger Gynecol Assoc. 2008;9:134–8.

    Google Scholar 

  62. Raine TR, Ricciotti N, Sokoloff A, Brown BA, Hummel A, Harper CC. An over-the-counter simulation study of a single-tablet emergency contraceptive in young females. Obstet Gynecol. 2012;119(4):772–9.

    PubMed  Article  Google Scholar 

  63. Shaaban OM, Hassen SG, Nour SA, Kames MA, Yones EM. Emergency contraceptive pills as a backup for lactational amenorrhea method (LAM) of contraception: a randomized controlled trial. Contraception. 2013;87(3):363–9.

    PubMed  Article  Google Scholar 

  64. Kesserü E, Larrañaga A, Parada J. Postcoital contraception with D-norgestrel. Contraception. 1973;7(5):367–79.

    Article  Google Scholar 

  65. De Santis M, Cavaliere AF, Straface G, Carducci B, Caruso A. Failure of the emergency contraceptive levonorgestrel and the risk of adverse effects in pregnancy and on fetal development: an observational cohort study. Fertil Steril. 2005;84(2):296–9.

    PubMed  Article  CAS  Google Scholar 

  66. Polakow-Farkash S, Gilad O, Merlob P, Stahl B, Yogev Y, Klinger G. Levonorgestrel used for emergency contraception during lactation-a prospective observational cohort study on maternal and infant safety. J Matern Fetal Neonatal Med. 2013;26(3):219–21.

    CAS  PubMed  Article  Google Scholar 

  67. Zhang L, Ye W, Yu W, Cheng L, Shen L, Yang Z. Physical and mental development of children after levonorgestrel emergency contraception exposure: a follow-up prospective cohort study1. Biol Reprod. 2014;91(1):27.

    PubMed  Article  CAS  Google Scholar 

  68. Carvajal A, Sainz M, Velasco V, Garcia Ortega P, Treceno C, Martin Arias LH, et al. Emergency contraceptive pill safety profile. Comparison of the results of a follow-up study to those coming from spontaneous reporting. Pharmacoepidemiol Drug Saf. 2015;24(1):93–7.

    PubMed  Article  Google Scholar 

  69. Rodriguez de Antonio LA, Fuentes B, Aguilar-Amat MJ, Diez-Tejedor E. Emergency contraception and stroke. A new case report. Med Clin (Barc). 2011;136(14):647–8.

  70. Lomana AV, Aznar JMF, Cuenca VH. Venous thrombosis of the upper extremity following the ingestion of levonorgestrel as an emergency contraceptive. Anales de Patologia Vascular. 2010;4(4):204–6.

    Google Scholar 

  71. Foer D, Buchheit KM, Gargiulo AR, Lynch DM, Castells M, Wickner PG. Progestogen hypersensitivity in 24 cases: diagnosis, management, and proposed renaming and classification. J Allergy Clin Immunol Pract. 2016;4(4):723–9.

    PubMed  Article  Google Scholar 

  72. Basu A, Candelier C. Ectopic pregnancy with postcoital contraception–a case report. Eur J Contracept Reprod Health Care. 2005;10(1):6–8.

    CAS  PubMed  Article  Google Scholar 

  73. Cabar FR, Pereira PP, Zugaib M. Intrauterine pregnancy after salpingectomy for tubal pregnancy due to emergency contraception: a case report. Clinics (Sao Paulo). 2007;62(5):641–2.

    Article  Google Scholar 

  74. Ghosh B, Dadhwal V, Deka D, Ramesan CK, Mittal S. Ectopic pregnancy following levonorgestrel emergency contraception: a case report. Contraception. 2009;79(2):155–7.

    PubMed  Article  Google Scholar 

  75. Jian Z, Linan C. Ectopic gestation following emergency contraception with levonorgestrel. Eur J Contracept Reprod Health Care. 2003;8(4):225–8.

    CAS  PubMed  Article  Google Scholar 

  76. Kaymak O, Simşek Y, Doğanay M, Yıldız Y, Mollamahmutoğlu L. Ectopic pregnancy following levonorgestrel emergency contraception: a case report. J Turk German Gynecol Assoc. 2010;11(3):168–9.

    Article  Google Scholar 

  77. Kitani Y, Ishiguro T, Kobayashi A, Tamura R, Ueda H, Adachi S, et al. Ectopic pregnancy following oral levonorgestrel emergency contraception use. J Obstet Gynaecol Res. 2019;45(2):473–6.

    PubMed  Article  Google Scholar 

  78. Kozinszky Z, Bakken RT, Lieng M. Ectopic pregnancy after levonorgestrel emergency contraception. Contraception. 2011;83(3):281–3.

    PubMed  Article  Google Scholar 

  79. Pereira PP, Cabar FR, Raiza LC, Roncaglia MT, Zugaib M. Emergency contraception and ectopic pregnancy: report of 2 cases. Clinics (Sao Paulo). 2005;60(6):497–500.

    Article  Google Scholar 

  80. Sheffer-Mimouni G, Pauzner D, Maslovitch S, Lessing JB, Gamzu R. Ectopic pregnancies following emergency levonorgestrel contraception. Contraception. 2003;67(4):267–9.

    CAS  PubMed  Article  Google Scholar 

  81. Steele BJ, Layman K. Ectopic pregnancy after plan b emergency contraceptive use. J Emerg Med. 2016;50(4):663–6.

    PubMed  Article  Google Scholar 

  82. Tan S, Bourke R, Roberts M, Chew M, Beilby R, Roach V. Heterotopic pregnancy after Postinor-2. Aust N Z J Obstet Gynaecol. 2004;44(5):460–1.

    PubMed  Article  Google Scholar 

  83. Sehgal A, Rani S, Singh A. Ectopic pregnancy following levonorgestrel postcoital contraceptive. J South Asian Feder Obst Gynae. 2017;9(2):131–2.

    Article  Google Scholar 

  84. Cameron S, Li H, Gemzell-Danielsson K. Current controversies with oral emergency contraception. BJOG. 2017;124(13):1948–56.

    CAS  PubMed  Article  Google Scholar 

  85. Puig Borràs C, Álvarez Álvarez BI. The history of universal access to emergency contraception in Peru: a case of politics deepening inequalities. Reprod Health Matters. 2018;26(54):47–50.

    PubMed  Article  Google Scholar 

  86. Plan B One-Step (levonorgestrel) tablet, 1.5 mg, for oral use. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf.

  87. Motta E, Golba A, Ostrowska Z, Steposz A, Huc M, Kotas-Rusnak J, et al. Progesterone therapy in women with epilepsy. Pharmacol Rep. 2013;65(1):89–98.

    CAS  PubMed  Article  Google Scholar 

  88. Moran MH, Smith SS. Progesterone withdrawal I: pro-convulsant effects. Brain Res. 1998;807(1–2):84–90.

    CAS  PubMed  Article  Google Scholar 

  89. Shiono S, Williamson J, Kapur J, Joshi S. Progesterone receptor activation regulates seizure susceptibility. Ann Clin Transl Neurol. 2019;6(7):1302–10.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  90. Shurie S, Were E, Orang’o O, Keter A. Levonorgestrel only emergency contraceptive use and risk of ectopic pregnancy in Eldoret Kenya: a case-control study. Pan Afr Med J. 2018;31:214.

    PubMed  PubMed Central  Google Scholar 

  91. Li C, Zhang H-Y, Liang Y, Xia W, Zhu Q, Zhang D, et al. Effects of levonorgestrel and progesterone on oviductal physiology in mammals. Reprod Biol Endocrinol. 2018;16(1):59.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  92. Chakhtoura Z, Canonico M, Gompel A, Thalabard JC, Scarabin PY, Plu-Bureau G. Progestogen-only contraceptives and the risk of stroke: a meta-analysis. Stroke. 2009;40(4):1059–62.

    CAS  PubMed  Article  Google Scholar 

  93. van Hylckama Vlieg A, Helmerhorst FM, Rosendaal FR. The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device. Arterioscler Thromb Vasc Biol. 2010;30(11):2297–300.

    Article  CAS  Google Scholar 

  94. de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014;(3):CD010813.

  95. Weill A, Dalichampt M, Raguideau F, Ricordeau P, Blotière P-O, Rudant J, et al. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. BMJ. 2016;353:i2002.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  96. Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet. 2018;141(3):287–94.

    PubMed  PubMed Central  Article  Google Scholar 

  97. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Contraception. 1998;57(5):315–24.

  98. Lidegaard O, Kreiner S. Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception. 2002;65(3):197–205.

    CAS  PubMed  Article  Google Scholar 

  99. Shaaban MM, Elwan SI, El-Kabsh MY, Farghaly SA, Thabet N. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation. Contraception. 1984;30(5):421–30.

    CAS  PubMed  Article  Google Scholar 

  100. Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, et al. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost. 2000;84(1):4–8.

    CAS  PubMed  Google Scholar 

  101. Ruan X, Neubauer H, Yang Y, Schneck H, Schultz S, Fehm T, et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric. 2012;15(5):467–72.

    CAS  PubMed  Article  Google Scholar 

  102. Sivik T, Jansson A. Progesterone and levonorgestrel regulate expression of 17betaHSD-enzymes in progesterone receptor positive breast cancer cell line T47D. Biochem Biophys Res Commun. 2012;422(1):109–13.

    CAS  PubMed  Article  Google Scholar 

  103. Neubauer H, Ma Q, Zhou J, Yu Q, Ruan X, Seeger H, et al. Possible role of PGRMC1 in breast cancer development. Climacteric. 2013;16(5):509–13.

    CAS  PubMed  Article  Google Scholar 

  104. Soini T, Hurskainen R, Grenman S, Maenpaa J, Paavonen J, Pukkala E. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. Obstet Gynecol. 2014;124(2 Pt 1):292–9.

    CAS  PubMed  Article  Google Scholar 

  105. Jareid M, Thalabard JC, Aarflot M, Bovelstad HM, Lund E, Braaten T. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study. Gynecol Oncol. 2018;149(1):127–32.

    CAS  PubMed  Article  Google Scholar 

  106. Averbach S, Silverberg MJ, Leyden W, Smith-McCune K, Raine-Bennett T, Sawaya GF. Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer. Contraception. Epub 17 Apr 2018. https://doi.org/10.1016/j.contraception.2018.04.008.

  107. Misra JS, Engineer AD, Tandon P. Cervical cytology associated with levonorgestrel contraception. Acta Cytol. 1995;39(1):45–9.

    CAS  PubMed  Google Scholar 

  108. Yoo YA, Son J, Mehta FF, DeMayo FJ, Lydon JP, Chung S-H. Progesterone signaling inhibits cervical carcinogenesis in mice. Am J Pathol. 2013;183(5):1679–87.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  109. Chung S-H. Targeting female hormone receptors as cervical cancer therapy. Trends Endocrinol Metab. 2015;26(8):399–401.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  110. Mehta FF, Baik S, Chung S-H. Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model. Oncotarget. 2017;8(2):2372–80.

    PubMed  Article  Google Scholar 

  111. Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA. Advance provision of emergency contraception for pregnancy prevention (full review). Cochrane Database Syst Rev. 2007;2:CD005497.

    Google Scholar 

  112. Sander PM, Raymond EG, Weaver MA. Emergency contraceptive use as a marker of future risky sex, pregnancy, and sexually transmitted infection. Am J Obstet Gynecol. 2009;201(2):146.

    PubMed  PubMed Central  Article  Google Scholar 

  113. Hall OJ, Klein SL. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal Immunol. 2017;10(5):1097–107.

    CAS  PubMed  Article  Google Scholar 

  114. Yao Y, Li H, Ding J, Xia Y, Wang L. Progesterone impairs antigen-non-specific immune protection by CD8 T memory cells via interferon-gamma gene hypermethylation. PLoS Pathog. 2017;13(11):e1006736.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  115. Levonorgestrel-containing IUDs: psychiatric adverse events. React Week. 2018;1704(1):9.

  116. Gingnell M, Engman J, Frick A, Moby L, Wikstrom J, Fredrikson M, et al. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill–a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology. 2013;38(7):1133–44.

    CAS  PubMed  Article  Google Scholar 

  117. Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of Hormonal Contraception With Depression. JAMA Psychiatry. 2016;73(11):1154–62.

    PubMed  Article  Google Scholar 

  118. Glick ID, Bennett SE. Psychiatric complications of progesterone and oral contraceptives. J Clin Psychopharmacol. 1981;1(6):350–67.

    CAS  PubMed  Article  Google Scholar 

  119. Skovlund CW, Morch LS, Kessing LV, Lange T, Lidegaard O. Association of hormonal contraception with suicide attempts and suicides. Am J Psychiatry. 2018;175(4):336–42.

    PubMed  Article  Google Scholar 

  120. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol. 2008;29(2):313–39.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  121. Jin J, Maren S. Prefrontal–hippocampal interactions in memory and emotion. Front Syst Neurosci. 2015;9:170.

    PubMed  PubMed Central  Article  Google Scholar 

  122. Sigurdsson T, Duvarci S. hippocampal–prefrontal interactions in cognition, behavior and psychiatric disease. Front Syst Neurosci. 2016;9:190.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  123. Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy: a meta-analysis of case–control studies. Contraception. 1995;52(1):23–34.

    CAS  PubMed  Article  Google Scholar 

  124. Romita P, Foti C, Calogiuri G, Cantore S, Ballini A, Dipalma G, et al. Contact dermatitis due to transdermal therapeutic systems: a clinical update. Acta bio-medica. 2018;90(1):5–10.

    PubMed  Google Scholar 

  125. Bondon-Guitton E, Bagheri H, Montastruc JL. Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database. J Clin Periodontol. 2012;39(6):513–8.

    PubMed  Article  Google Scholar 

  126. Brinker A, Beitz J. Use of a spontaneous adverse drug events database for identification of unanticipated drug benefits. Clin Pharmacol Ther. 2002;71(1):99–102.

    PubMed  Article  Google Scholar 

  127. Buccellato E, Biagi C, Vaccheri A, Melis M, Montanaro N, Motola D. Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). Expert Opin Drug Saf. 2013;12(5):615–9.

    PubMed  Article  Google Scholar 

  128. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995;346(8990):1589–93.

    CAS  PubMed  Article  Google Scholar 

  129. Etminan M, Delaney JA, Bressler B, Brophy JM. Oral contraceptives and the risk of gallbladder disease: a comparative safety study. CMAJ. 2011;183(8):899–904.

    PubMed  PubMed Central  Article  Google Scholar 

  130. Manzouri L, Parhizkar S, Mohammadi N. Comparison the effectiveness and side effects of two methods of emergency contraception: levonorgestrel versus LD, HD. Maturitas. 2015;81(1):194–5.

    Article  Google Scholar 

  131. van Rooijen M, Silveira A, Thomassen S, Hansson LO, Rosing J, Hamsten A, et al. Rapid activation of haemostasis after hormonal emergency contraception. Thromb Haemost. 2007;97(1):15–20.

    PubMed  Article  CAS  Google Scholar 

  132. Task Force on Post-Ovulatory Methods for Fertility Regulation. Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. Contraception. 2000;61(5):303–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand

    Nattawut Leelakanok

  2. Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Pharmacokinetic Research Unit, Naresuan University, Phitsanulok, Thailand

    Janthima Methaneethorn

  3. Center of Excellence for Environmental Health and Toxicology, Naresuan University, Phitsanulok, Thailand

    Janthima Methaneethorn

Authors
  1. Nattawut Leelakanok
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janthima Methaneethorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NL and JM designed the research and conducted the systematic review and meta-analysis. NL wrote the paper and had primary responsibility for the final content. Both authors read and approved, and are in agreement with, the final version submitted for publication. The content has not been published elsewhere.

Corresponding author

Correspondence to Nattawut Leelakanok.

Ethics declarations

Funding

This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest

Nattawut Leelakanok and Janthima Methaneethorn declare they have no conflicts of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 196 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leelakanok, N., Methaneethorn, J. A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive. Clin Drug Investig 40, 395–420 (2020). https://doi.org/10.1007/s40261-020-00901-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-020-00901-x